Beta-Cell FunctionBody Mass IndexGlycemic ControlGut MicrobiotaHbA1c

Association between small intestinal bacterial overgrowth and beta-cell function of type 2 diabetes

  • 2020
  • Li-hui Yan, Biao Mu, Da Pan, et al.
Why this matters for your gut health

Type 2 diabetes (T2DM) involves reduced insulin secretion and insulin resistance, and small intestinal bacterial overgrowth (SIBO) has been increasingly linked to metabolic diseases. While prior research connected SIBO to diabetic complications like gastrointestinal symptoms and neuropathy, almost no studies had examined whether SIBO directly affects beta-cell function (the pancreatic cells responsible for insulin production). Understanding this link could open new avenues for improving glycemic control in T2DM patients by targeting gut bacteria.

Summary

This retrospective observational study examined 104 T2DM patients from Tianjin Medical University Chu Hsien-I Memorial Hospital (April 2016–August 2018), split into SIBO-positive (56 patients) and SIBO-negative (48 patients) groups based on glucose H2/CH4 breath testing. All underwent oral glucose tolerance tests (OGTT) to assess insulin sensitivity (1/HOMA-IR, ISIM) and insulin release (HOMA-β, early-phase and total-phase insulin secretion indices). The study found SIBO-positive patients had worse glycemic markers and lower insulin secretion than SIBO-negative patients, suggesting SIBO may impair beta-cell function independent of other factors.

Key findings

  • SIBO prevalence was 53.85% among T2DM patients studied
  • SIBO-positive patients had significantly lower BMI (26.67 vs 28.67 kg/m²)
  • SIBO-positive patients showed higher HbA1c (8.70% vs 7.40%) and higher 120-minute glucose levels
  • SIBO-positive patients had lower insulin levels at all OGTT time points (0, 30, 60, 120, 180 min)
  • SIBO-positive patients showed lower HOMA-β, early-phase InsAUC30/GluAUC30, and total-phase InsAUC120/GluAUC120 (all indicating reduced insulin release)
  • Multiple linear regression showed SIBO, fasting glucose, and BMI were independently associated with both early-phase (P=0.044) and total-phase (P=0.034) insulin secretion
  • Proposed mechanism: SIBO-related endotoxemia may activate inflammatory pathways (NF-κB, TLR4) that impair islet cell insulin secretion
  • Study limitations: small sample size, no healthy control group, single-center design, cross-sectional (no causality established)

Read the full paper
VIEW PDF
Citation

Yan L, Mu B, Pan D, Shi Y, Yuan J, Guan Y, Li W, Zhu X, Guo L. Association between small intestinal bacterial overgrowth and beta-cell function of type 2 diabetes. J Int Med Res. 2020;48(7):1-10. doi:10.1177/0300060520937866

Related Research Papers
n